March 18, 2020


Over the past several years, the life sciences industry began monitoring clinical trial data remotely through a centralized review process as part of a risk-based monitoring strategy. This practice reduces the frequency and nature of on-site monitoring performed by Clinical Research Associates (CRAs) – a practice that is costly, inefficient, impractical, and time consuming.

Image or Video 

However, the various iterations of the tools available to support remote monitoring have not met all the needs of either Sponsors or Contract Research Organizations (CROs), hindering efforts to adopt Central Monitoring more completely and successfully. Here we review the evolution of Central Monitoring solutions and introduce a new Central Monitoring Clinical Review (CMCR) Dashboard that has the potential to dramatically change risk-based monitoring approaches and reduce costs related to bringing new therapies to market.

Click the download button for the full PDF of this report.